ALBERT RIDGEWAY: Open Payments
NPI 1326013558 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 40 payments from 12 companies in 2025. Trend: 2023 $462 · 2024 $956 · 2025 $913
Food & beverage: $834Education: $79
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $179 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Inspire Medical Systems, Inc. | 1 | $129 |
| Insmed, Inc. | 4 | $93 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| GENZYME CORPORATION | 5 | $78 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| Indivior Inc. | 3 | $53 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: DUPIXENT, INSPIRE, NUCALA, Arikayce, TRELEGY ELLIPTA, SUBLOCADE, XYWAV, ZERBAXA.
Industry payments across AL — which companies pay providers there.
